tirzepatide dosing vs semaglutide Evaluating Dose Titration in and for Weight Loss: A Retrospective Academic Call Center Study Subcutaneously administered tirzepatide vs semaglutide

105(4): e47365

Neuroscientists generally agree build-ups of amyloid and tau proteins in the brain cause toxicity that can lead to Alzheimers

Importantly, we did not observe evidence of increased surgical risk, which is reassuring given concerns about perioperative management. Additionally, scientists discovered the use of GLP-1s was also linked to significantly lower surgical site infection rates among patients undergoing TKA and THA

Morton RW, Murphy KT, McKellar SR, Schoenfeld BJ, Henselmans M, Helms E, et al

Bone loss can also occur while on semaglutide, or with any form of rapid weight loss

Vigilance is important throughout treatment